These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15859166)

  • 1. Interferon-alpha: a clinical update.
    Rieger PT
    Cancer Pract; 1995; 3(6):356-65. PubMed ID: 15859166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene modulatory effects, pharmacokinetics, and clinical tolerance of interferon-alpha1b: a second member of the interferon-alpha family.
    Masci P; Olencki T; Wood L; Rybicki L; Jacobs B; Williams B; Faber P; Bukowski R; Tong K; Borden EC
    Clin Pharmacol Ther; 2007 Mar; 81(3):354-61. PubMed ID: 17339865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
    Maruoka M; Fujimura M; Kawamura K; Suzuki S; Hamano M; Nishikawa Y; Nagayama T
    Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary side effects of interferon-alpha therapy in patients with hematological malignancies.
    Anderson P; Höglund M; Rödjer S
    Am J Hematol; 2003 May; 73(1):54-8. PubMed ID: 12701122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of oromucosally administered interferon-alpha in the prevention and treatment of animal diseases.
    Dec M; Puchalski A
    Pol J Vet Sci; 2008; 11(2):175-86. PubMed ID: 18683548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of imatinib in patients with chronic myeloid leukemia and complete or near-complete cytogenetic response to interferon-alpha.
    Branford S; Hughes T; Milner A; Koelmeyer R; Schwarer A; Arthur C; Filshie R; Moreton S; Lynch K; Taylor K
    Cancer; 2007 Aug; 110(4):801-8. PubMed ID: 17607681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nursing management of patients with malignant melanoma receiving adjuvant alpha interferon-2b.
    Kiley KE; Gale DM
    Clin J Oncol Nurs; 1998 Jan; 2(1):11-6. PubMed ID: 9481251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous reactions associated with alpha interferon therapy.
    Stafford-Fox V; Guindon KM
    Clin J Oncol Nurs; 2000; 4(4):164-8. PubMed ID: 11261097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
    Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
    Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of interferon-alpha in the treatment of chronic myeloid leukemia.
    Kujawski LA; Talpaz M
    Cytokine Growth Factor Rev; 2007; 18(5-6):459-71. PubMed ID: 17703986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A perspective on the clinical effectiveness and tolerance of interferon-alpha.
    Borden EC; Parkinson D
    Semin Oncol; 1998 Feb; 25(1 Suppl 1):3-8. PubMed ID: 9482534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy.
    Balan V; Nelson DR; Sulkowski MS; Everson GT; Lambiase LR; Wiesner RH; Dickson RC; Post AB; Redfield RR; Davis GL; Neumann AU; Osborn BL; Freimuth WW; Subramanian GM
    Antivir Ther; 2006; 11(1):35-45. PubMed ID: 16518958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alpha interferon in children with Philadelphia chromosome-positive chronic myeloid-leukaemia].
    Ben Lakhal R; Aissaoui L; Jeddi R; Ayari B; Ben Abid H; Belhadj Ali Z; Gouider E; Meddeb B; Hafsia R; Hafsia A
    Tunis Med; 2005 May; 83(5):296-9. PubMed ID: 16044905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of adjuvant intraperitoneal alpha-interferon in stage III ovarian cancer patients who have no evidence of disease after primary surgery and chemotherapy: An intergroup study.
    Alberts DS; Hannigan EV; Liu PY; Jiang C; Wilczynski S; Copeland L; Markman M
    Gynecol Oncol; 2006 Jan; 100(1):133-8. PubMed ID: 16153694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alpha therapy for patients with essential thrombocythemia: final results of a phase II study initiated in 1986.
    Saba R; Jabbour E; Giles F; Cortes J; Talpaz M; O'Brien S; Freireich EJ; Garcia-Manero G; Kantarjian H; Verstovsek S
    Cancer; 2005 Jun; 103(12):2551-7. PubMed ID: 15861412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatigue: definitions, mechanisms, and paradigms for study.
    Dalakas MC; Mock V; Hawkins MJ
    Semin Oncol; 1998 Feb; 25(1 Suppl 1):48-53. PubMed ID: 9482540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to interferon in patients undergoing IFN therapy: an update.
    Antonelli G
    J Biol Regul Homeost Agents; 1995; 9(4):123-31. PubMed ID: 8844336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
    J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.